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ABSTRACT
Background
Model organisms are widely used in research, especially in the context of complex
situations. One model organism that has been widely used is the common fruit fly,
Drosophila melanogaster (D. mel). D. mel are most commonly used in the context of
genetics, but they have also been widely used in research focusing on general anesthetics.
One value that has not been measured in D. mel, however, as it relates to general
anesthetics, is the decrement times.
Methods
Flies were exposed to 40 µL of the anesthetic isoflurane or sevoflurane in a
centrifuge tube for 10 minutes, after which the flies were allowed to recover for various
amounts of time. The anesthetic was then extracted using dichloromethane (DCM) and
enflurane was added as an internal standard.
Results
The decrement times of male flies with isoflurane were found to be approximately
30 seconds for the 50% decrement, 2 minutes for the 80%, and 3 minutes for the 90%
decrement. For female flies the values found with isoflurane were found to be
approximately 30 seconds for the 50% decrement and 4 minutes for the 80% decrement.
The values found for the 50% decrement time of sevoflurane were about 5 minutes for the
female flies and 2 minutes for the male flies, but the values found in female flies with
sevoflurane were not consistent.

vii
Conclusions
Though the data with sevoflurane were inconsistent, those collected with isoflurane
give valuable insight into general anesthetics. This information can be used in future work
involving drosophila flies and anesthetics in order to gain a deeper understanding of how
inhalational anesthetics work.
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INTRODUCTION
The first publicized use of anesthetics was nearly 200 years ago in 1846, and
since then the use of anesthetics has become more common and safer for the patient.1,2
There are still many dangers of anesthetics, however, especially associated with
prolonged and early exposure to anesthetic gases.3,4,5,6,7 Although many discoveries have
been made, there are still many aspects of anesthesia that are not well understood. One
way to further understand anesthesia is through the use of model organisms. A recent
discovery that used model organisms found that stimulation or inhibition of certain
neurons in the hypothalamus of mice had a correlation with quality and duration of
sleep.8 To be used as a model organism, research must indicate that the organism
responds to given stimuli in a way similar to how humans respond. This data can then be
used to better understand the stimuli in humans. The fruit fly, Drosophila melanogaster
(D. mel)¸ is commonly used as a model organism, especially in the context of genetics,
and has been said to be the model organism for genetics.9 While genetics is the arena
where D. mel has the most acclaim, the organism can be a model in many other
applications.
One application for which D. mel has been used as a model is with anesthetics.
Karunanithi et al. explored how D. mel are similar to humans in the way their minds and
bodies react to anesthetics.10 They present a basic overview of anesthesia and how it
affects different levels of consciousness and discuss a few experiments with anesthetics
and D. mel, such as using propofol-laced food in order to monitor activity of flies with
different levels of anesthesia exposure. In 2017, MacMillan et al. explored the effects of
isoflurane and sevoflurane anesthetics on many different aspects of health in D. mel
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including fecundity, starvation, and temperature tolerances. MacMillan et al. found that
D. mel generally recovers more quickly from sevoflurane than isoflurane after similar
exposure times.11 It was also found that with increased exposure time, the recovery time
was more sex-dependent in isoflurane than in sevoflurane and that the fecundity of
female flies was not significantly affected by either sevoflurane or isoflurane.
D. mel has been used in many different experiments to determine how anesthesia
affects different organisms and how its effects can change based on genetics and
sex.10,11,12,13,14,15 Many properties of anesthetics have been measured in the organism. One
property of anesthetics that is very important to those who work in the field of
anesthesiology is the minimum alveolar concentration (MAC). The minimum alveolar
concentration is a measure of how saturated the alveoli in the lungs must be with an
anesthetic before approximately half of all humans will not react to a surgical incision.16
Zalucki et. al. found the MAC value of isoflurane in D. mel to be 0.2-0.6% depending on
the criteria used to determine if the fly is conscious.15 Consciousness was determined
through a startle response, but the MAC was found to be higher if the test involved what
the authors described to be more complex behavior, such as reacting to a light beam
rather than reacting to a vibration.
One property of anesthetics that has not been measured in D. mel is the decrement
times. The decrement time of an anesthetic is defined as the amount of time necessary for
a given percentage of that anesthetic to have left the organism.16 In 1997, Bailey
calculated the decrement times of isoflurane, sevoflurane, enflurane, and desflurane in
humans.17 Bailey found that after 6 hours of exposure, enflurane has the longest 90%
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decrement time, at about 100 minutes, with isoflurane at 86 minutes, sevoflurane at 65
minutes, and desflurane being considerably lower than the rest at 14 minutes.
Knowing the decrement times of different anesthetic gases in D. mel will further
establish the organism as a model for volatile anesthetic properties in humans.
Additionally, due to their quick generation times, D. mel could be used to explore
relationships between genetics and anesthetics, such as finding links between being more
or less resistant to the effects of anesthetics. In this experiment, the decrement times of
isoflurane and sevoflurane in male and female D. mel will be measured using gas
chromatography-mass spectrometry (GC/MS).

MATERIALS AND METHODS
Wild-type drosophila flies (Carolina, catalog number 172100) were kept in
culture vials and fed drosophila fly medium with yeast placed in the media and hydrated
using sterile water. Flies were allowed to propagate and were transferred to new vials
every month or so. The vials were stored in a Fisher Scientific 307C Isotemp Low
Temperature Incubator/Freezer set to 21.0 ˚C. No special attention was paid to using
virgin female flies, thus flies were removed from vials and tested when necessary.
Because male and female drosophila flies have been found to have different
recovery times, which would imply different decrement times, the flies were first sorted
male and female.11 This was done by removing flies from the culture vial to a new vial
without medium. Flynap was then administered to the flies until they were all asleep, not
exceeding two minutes of exposure. The flies were then placed on a notecard under a
dissection microscope and sorted into two piles based on sex. Images of male and female
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flies have been included in Figure 1. It should also be noted that female flies are typically
larger than male flies, but because this can vary based on genetics, all flies were sexed by
flipping the fly over and checking the genitalia.

Figure 1a. Male drosophila fly. Notice the darker genitals and smaller size. 1b. Female drosophila
fly. Notice the lighter, smooth genitals and larger size.

After the flies were sorted, they were placed in empty culture vials overnight to

allow them to recover, and to ensure that the Flynap had no effect on responses to the
anesthetics being tested. The following day, the flies were transferred from the culture
vials into a conical centrifuge tube. A foam disc was then inserted into the top of the tube,
to ensure that the flies would not be able to escape. Into this foam disc was injected 40
µL of isoflurane or sevoflurane, depending on which anesthetic was being tested. This
volume was chosen because it was used in a previous study and is enough the saturate the
environment.11 The cap was placed on the centrifuge tube to keep the anesthetic inside
the tube, and the flies breathed the anesthetic for 10 minutes. At 10 minutes, the flies
were transferred to a glass centrifuge tube, and were either allowed to recover, or, in the
case of the control group, immediately killed by pouring dichloromethane (DCM) into
the vial. At this point, an enflurane internal standard was also added to the vial. Enflurane
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was chosen as it makes for a good internal standard when analyzing anesthetics due to its
similar properties.18 The internal standard was added as soon as possible to ensure any
mistakes made during the procedure also affected the concentration of internal standard.
The internal standard solution was made by diluting 40 µL of enflurane in DCM to a total
volume of 10 mL.
The flies were then homogenized using a glass stir rod, to extract all the
anesthetic from their bodies by the DCM. This solution was then removed from the vial
and diluted to 5 mL in order to be sure that every trial was the same volume no matter
how much was removed into the GC/MS vial. While the quantities could have been
normalized by diluting the samples to a constant mass, it was more convenient to dilute to
a constant volume, and did not reduce the accuracy of the measurements any more than
normalizing by other means.
Before data was collected, the response factor of the internal standard (IS) being
used, enflurane, was calculated with both isoflurane and sevoflurane. These were run in
equal concentrations and the following equation was used to calculate response factor
(F):
𝐹𝐹 ∗

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐼𝐼𝐼𝐼 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴
=
[𝐼𝐼𝐼𝐼]
[𝐴𝐴]

Where “IS” represents the internal standard, and “A” represents the analyte,
which was either isoflurane or sevoflurane, depending on the trial. Two trials were run
for both isoflurane and sevoflurane, and these values can be found in Table 1.
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Table 1 Response factors (F) calculated to be 6.945 and 0.626 for isoflurane and sevoflurane,
respectively. Because equal volumes of internal standard (IS) and analyte (A) were used, the ratio of
analyte to IS was equal to F. The average of the two runs was then calculated for use later.

Trial
Isoflurane
Sevoflurane

Mean* Analyte
Peak Area
1284872

Mean* Enflurane Peak
Area
184986

Mean* Response
Factor (F)
6.945

117986

188549

0.626

*n=2

The GC/MS used was a Shimadzu GCMS-QP2010 SE and the column used was a
Rtx-5MS column of length 30.0 m, diameter 0.25 mm, and thickness 0.25 µm. Since
DCM elutes later than isoflurane, sevoflurane, and enflurane, the mass spectrometer
sensor was turned off around the 2-minute mark to avoid overstimulating the sensor.
Typically, the solvent elutes first, thus there is a solvent cut-off time, meaning the sensor
waits to turn on until after the solvent has eluted. But because the solvent eluted later than
the compounds being analyzed, it was decided to turn the sensor off after the analytes
were measured.
The method used was adapted from MacMillan et al. and was as follows.11 The
column oven temperature was 30.0 ˚C. The injection temperature was 200.0 ˚C. A split
injection mode was used with a split ratio of 1:50.0. The total flow was set to 54.7
mL/min with a column flow of 1.01 mL/min. The column oven temperature started at
30.0 ˚C and held at that temperature for 4.00 minutes. The temperature then increased at a
rate of 40.00 ˚C/min to a temperature of 140.0 ˚C, which was held for 5.00 minutes.

RESULTS
Approximately thirty female Drosophila melanogaster (D. mel) flies were
exposed to 40 µL of isoflurane in a conical centrifuge for 10 minutes. The flies were then
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homogenized, and the anesthetic was extracted using dichloromethane (DCM). An
enflurane internal standard was added and the sample was analyzed by gas
chromatography-mass spectrometry (GC/MS) to determine the amount of anesthetic
present. Different trials were run allowing the flies to recover for different periods of
time, which is referred to as the “recovery time” in Table 2. These data show the 50%
decrement time of isoflurane in female D. mel flies to be 1 minute. A 75% decrement
time for isoflurane was also found to be approximately 4 minutes.
Table 2 Female flies have an approximate 50% decrement time of 1 minute using isoflurane. Percent
decrement is calculated based on the control group.

Isoflurane
Recovery Number Isoflurane Enflurane concentration Isoflurane/fly
Time
of flies peak area peak area
(ppm)
(ppm)
3
Control
30
15380
5983
1.48x10
49.4

Percent
decrement
0

0.5 min

21

5106

5388

5.46x102

26.0

47.34

1 min

30

7097

5447

7.50x102

25.0

49.31

2 min

31

3751

5053

4.28x102

13.8

72.05

3 min

32

4471

4496

5.73x102

17.9

63.73

4 min

26

3350

6305

3.06x102

11.8

76.15

The amount of isoflurane was calculated from the same equation used to calculate
the response factor, F. Thus, the value calculated for the 0.5-minute recovery trial was
calculated as follows:
𝐹𝐹 =

(𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 /𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐼𝐼𝐼𝐼 )
([𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎]⁄[𝐼𝐼𝐼𝐼])

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 ⁄𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐼𝐼𝐼𝐼
[𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎] = �
� ∗ ([𝐼𝐼𝐼𝐼])
𝐹𝐹
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The value used for the concentration of internal standard ([IS]) was 0.004,
because the internal standard was prepared by diluting 40 µL to 10.00 mL with DCM.
The value calculated for the concentration of anesthetic was then divided by the number
of flies in that trial, to standardize the amount of anesthetic present. Care was taken to
remove any dead flies from the centrifuge tube before exposure to anesthetic, as they
were not breathing the anesthetic, and would artificially decrease the amount of
anesthetic detected per fly.
The same procedure as described above was used to determine percent
decrements of isoflurane in male D. mel flies. These data were compiled in Table 3. As
can be seen by the data, the 50% decrement time of isoflurane in male flies was
calculated to be approximately 30 seconds. The 80% decrement time was found to be 2
minutes, and the 90% decrement time was found to be 3 minutes, at which point the
metabolization of the anesthetic seems to have slowed down, leading to a percent
decrement of 90% after 4 minutes of recovery as well.
Table 3 Male flies have an approximate 50% decrement time of 30 seconds using isoflurane. Percent
decrement is calculated based on the control group.

Isoflurane
Recovery Number Isoflurane Enflurane concentration Isoflurane/fly
Time
of flies peak area peak area
(ppm)
(ppm)
Control
29
21681
5739
2.18x103
75.0

Percent
decrement
0

0.5 min

29

9010

4958

1.05x103

36.1

51.90

1 min

21

2816

4505

3.60x102

17.1

77.15

2 min

32

3978

4598

4.98x102

15.6

79.24

3 min

25

1689

6202

1.57x102

6.27

91.64

4 min

23

1414

5607

1.45x102

6.31

91.58
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The data collected for sevoflurane were less consistent than those collected for
isoflurane in both male and female flies. The data collected for female flies using
sevoflurane can be found in Table 4, and those collected with male flies are found in
Table 5. Though there were some inconsistencies in the data collected using isoflurane
(for example, the percent decrement after a 3-minute recovery time being lower than that
of a 2-minute recovery in the female flies), they were not as bad as those noted during the
collection of data using sevoflurane. One observation that can be made regarding the
sevoflurane data, however, is how long the female flies were able to retain the anesthetic,
showing only a 3% decrement after two minutes. This contradicts what was found by
MacMillan et al. when measuring recovery times, which found that D. mel recover faster
from sevoflurane.11
Table 4 Sevoflurane decrement times in female flies are inconsistent. Percent decrement is calculated
based on the control group. Notice the very low percent decrement after 2 minutes of recovery.

Sevoflurane
Recovery Number Sevoflurane Enflurane concentration Sevoflurane
Percent
Time
of flies
peak area peak area
(ppm)
/fly (ppm) decrement
Control
28
4247
5407
5.02x103
179
0
2 min

30

4905

6011

5.22x103

174

3.04

5 min

31

1740

4714

2.36x103

76.1

57.55

8 min

34

2969

4167

4.56x103

134

25.30

10 min

25

0

4707

0

0

100

10
Table 5 Sevoflurane decrement times in male flies are inconsistent. Percent decrement is calculated based
on the control group.

Sevoflurane
Recovery Number Sevoflurane Enflurane concentration Sevoflurane
Time
of flies
peak area peak area
(ppm)
/fly (ppm)
4
Control
31
7897
4598
1.10x10
354

Percent
decrement
0

1 min

29

2081

4922

2.70x103

93.2

73.68

2 min

27

4277

5918

4.62x103

171

51.69

3 min

39

4560

9534

3.06x103

78.4

77.86

5 min

32

4619

8626

3.42x103

107

69.80

7 min

22

0

5304

0

0

100

DISCUSSION
The decrement times of isoflurane and sevoflurane in D. mel have not been
measured and published to date. In order to measure this, male and female flies were
separately exposed to 40 µL of isoflurane or sevoflurane for 10 minutes, killed, and the
anesthetic was extracted using dichloromethane. The relative amounts of anesthetic were
measured using gas chromatography-mass spectrometry, and it was found that the 90%
decrement times for isoflurane for male flies was about 3 minutes. The 50% decrement
times were also found to be around 30 seconds for female flies and slightly less than this
for male flies, though an exact number for male flies was unknown due to the difficulty
of extracting the anesthetic that quickly. The highest decrement times found for
isoflurane in the female flies was the 80% decrement time at a little longer than 4
minutes.
It is difficult to measure specific decrement times accurately due to how they are
measured. Because the flies must be killed in order to measure the decrement time, and
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because the time must be chosen before the percent decrement can be measured, it would
be difficult to determine the exact time at which the anesthetic is at 50% the original
concentration. While it would be possible to use regression analysis to predict decrement
times between those measured, the data were not consistent enough for this to be useful.
Additionally, specific decrement times are not as useful clinically as knowing general
decrement times, such as 50%, 80%, and 90%.
The decrement times of sevoflurane are harder to determine based on the data
collected. For female flies, the 50% decrement time was found to be a little under 5
minutes, but with a recovery time of 8 minutes, the decrement was found to be only 25%.
A trial with a recovery time of 10 minutes using female flies found no sevoflurane peak,
so it can be said that the 100% decrement time is somewhere between 8 minutes and 10
minutes. For male flies using sevoflurane, the data was similarly inconsistent. Like with
the female flies, the only thing that can be said about the decrement times of sevoflurane
in male flies is that the 100% decrement time is somewhere between 5 minutes and 7
minutes, as no sevoflurane peak was found after a recovery time of 7 minutes.
Another inconsistency noted in the sevoflurane data is the longer decrement times
of sevoflurane found as compared to those of isoflurane. This is inconsistent with
previously published data that focused on recovery times, rather than percent decrements.
The data previously published found that Drosophila flies recover from isoflurane in
approximately 12 minutes, whereas the recovery time found for sevoflurane was found to
be approximately 5 minutes.11 Based on this data, it would make sense to expect longer
decrement times in isoflurane, but this is not what was observed. This also contrasts the
data published by Bailey in 1997, which show that after 100 minutes of exposure, the
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90% decrement times of isoflurane and sevoflurane in humans are 86 and 65 minutes,
respectively.17 An explanation for this can be understood, however, by comparing the
minimum alveolar concentrations (MACs) of isoflurane and sevoflurane.
As previously mentioned, the MAC is the percent of alveoli in the lungs that must
be saturated for half of the population to not react to a surgical stimulus such as an
incision. When measured in humans, these values are found to be approximately 0.85 and
1.71% for isoflurane and sevoflurane, respectively.19,20 Taking this into account, the
longer decrement times in sevoflurane can be understood. That is, though the flies retain
sevoflurane longer than they do isoflurane, they do not retain enough to remain
unresponsive, and thus have a shorter recovery time with sevoflurane.
One possible reason for the inconsistency in the data for sevoflurane is that
sevoflurane may be metabolized by D. mel in some way that is unknown and that can
occur at different rates under different circumstances. Though the environment during
collection of data was never greatly changed, there may be some unknown factor that
caused this change in metabolism. Another possible reason is some genetic mutation that
occurred in the flies during testing, causing a change in metabolism of sevoflurane.14
As mentioned before, the decrement times of anesthetics in Drosophila
melanogaster have yet to be published, even though D. mel is a common model
organism. Though the data collected using sevoflurane were inconsistent, the values
found for isoflurane showed consistency and can be used in future work involving
drosophila flies and anesthetics to gain a deeper understanding of how inhalational
anesthetics work.
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The mechanism of action of anesthetics is still largely debated. A study recently
published found a correlation between stimulation or inhibition of certain neurons in the
hypothalamus of mice and quality and duration of anesthetic-induced sleep, but this
experiment used injected anesthetics.8 The data collected in this experiment could be
used in further research to determine how inhalational anesthetics affect the brain.
Additionally, the biochemical reactions behind the metabolism of anesthetics are
still largely unknown. Knowing the decrement times of volatile anesthetics in Drosophila
flies can help in the process of determining how anesthetics are metabolized by the flies,
which can in turn help give evidence of how they are metabolized by humans. This could
be done by determining the kinetics of the reactions occurring during the metabolism of
anesthetics, one important factor of which is how long these reactions take. Though
studies have been done exploring the kinetics of isoflurane in the body and in model
organisms, the exact mechanism of metabolism is unknown.21
This experiment is limited by the fact that the data must be interpreted in the
context of the procedure conducted. That is, the flies were exposed to anesthetic for 10
minutes, whereas in some experiments, such as those exploring prolonged exposure to
anesthetics, they may be exposed for much longer than that.4,5,6,7,22 The amount of time
the flies were exposed to anesthetic in the present experiment was chosen because 10
minutes is a relatively short amount of time, while still giving enough exposure to the
anesthetic for the concentration to be detected. Additionally, this exposure time has been
used in previous experiments using volatile anesthetics and D. mel.10,11 The amount of
anesthetic the flies were exposed to saturates the centrifuge tube and makes adding any
more anesthetic superfluous.11 While this does present a challenge when applying this
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data to other situations, the data is nonetheless novel and can still be helpful in future
research.
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